Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Botox Could Treat Enlarged Prostate


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Alzheimer's Disease
Ankylosing Spondylitis
Baldness
More...

Related Healthscout Videos
 border=
Bladder Control for Women
Zapping Vocal Tumors
Keep Away Ovarian Cancer
Breakthrough for Fatal Lung Disease
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Cialis
Coumadin
Detrol LA
More...

Related News Articles
 border=
Low Vitamin D Tied to Depression in Older Adults
Sen. Edward Kennedy Hospitalized After Seizure
Vitamin D Use Linked to Lower Mortality in Kidney Patients
Outcomes Similar for Laparoscopic, Open Colon Cancer Surgeries
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

Between 40 percent and 50 percent of BPH patients develop a loss of bladder control as the growing prostate squeezes against the urethra, the passage through which urine flows.

Accompanying symptoms include a frequent need to urinate (often at night), trouble urinating (even when feeling the urge), blood in the urine, and urinary tract infections. In severe cases, bladder and kidney damage can result.

Physicians diagnose BPH by means of digital rectal exams, blood tests, X-rays, sonograms, or cystoscopy -- the insertion of a lighted tube into the bladder.

Text Continues Below



Once identified, patients with mild BPH may choose to forego treatment. However, those with more serious symptoms are often prescribed medications to shrink or relax the gland to relieve bladder blockage.

Doctors use a number of drugs, often in combination, to treat BPH. When that fails, the prostate can be reduced or removed via laser or microwave techniques, or invasive surgery.

In this study, Chancellor and his colleagues honed in on Botox as a possible treatment alternative.

The researchers focused on 37 men, averaging 67 years of age, who had not responded to standard treatments for BPH.

Using an ultrasound guide, the patients were injected once with between 100 and 200 units of Botox, depending on the size of the prostate.

The team found that nearly three-quarters of the patients experienced a 30 percent improvement in their symptoms for up to a year following the injection. None of the patients experienced significant side effects, such as erectile dysfunction or urinary incontinence.

Follow-up exams conducted six months and 12 months following treatment also showed an up to 15 percent reduction in prostate size among some, but not all, patients. According to the researchers, this suggests Botox instigated a controlled form of prostate cell death that shrank the gland.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 5/23/2007

Related Links
 border=
From Healthscout's partner site on prostate, ProstateCommons.com
Prostate Check: Test yourself for symptoms online
Video: Prostate ultrasounds may save lives
Treatment: Get information about enlarged prostate treatments





New Features

New ADHD Site!

SOURCES: Michael B. Chancellor, M.D., professor, urology, University of Pittsburgh Medical Center; Peter T. Scardino, M.D., chairman, department of urology and head of Prostate Cancer Program, Memorial Sloan-Kettering Cancer Center, New York, N.Y.; Robert E. Weiss, M.D., urologic oncologist, Cancer Institute of New Jersey. and associate professor, urology, Robert Wood Johnson Medical School, New Brunswick, N.J.; May 19-24, 2007, American Urological Association annual meeting, Anaheim, Calif.


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map